Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 2,707,000 | 2,631,000 | 2,493,000 | 2,561,000 | 2,393,000 |
| Cost of Goods | 777,000 | 758,000 | 730,000 | 730,000 | 672,000 |
| Gross Profit | 1,930,000 | 1,873,000 | 1,763,000 | 1,833,000 | 1,720,000 |
| Operating Expenses | 1,547,000 | 1,489,000 | 1,222,000 | 1,513,000 | 1,332,000 |
| Operating Income | 383,000 | 384,000 | 541,000 | 319,000 | 388,000 |
| Interest Expense | 95,000 | 89,000 | 109,000 | 65,000 | 58,000 |
| Other Income | -197,000 | -150,000 | 25,000 | 42,000 | 126,000 |
| Pre-tax Income | 91,000 | 145,000 | 457,000 | 296,000 | 456,000 |
| Income Tax | -35,000 | -9,000 | 33,000 | -90,000 | 24,000 |
| Net Income Continuous | 126,000 | 154,000 | 424,000 | 386,000 | 432,000 |
| Net Income | $126,000 | $154,000 | $424,000 | $386,000 | $432,000 |
| EPS Basic Total Ops | 0.09 | 0.11 | 0.31 | 0.28 | 0.31 |
| EPS Basic Continuous Ops | 0.09 | 0.11 | 0.31 | 0.28 | 0.31 |
| EPS Diluted Total Ops | 0.09 | 0.11 | 0.30 | 0.27 | 0.31 |
| EPS Diluted Continuous Ops | 0.09 | 0.11 | 0.30 | 0.27 | 0.31 |
| EBITDA(a) | $383,000 | $384,000 | $541,000 | $318,000 | $389,000 |